295 related articles for article (PubMed ID: 10519918)
1. Bioactivities of chalcones.
Dimmock JR; Elias DW; Beazely MA; Kandepu NM
Curr Med Chem; 1999 Dec; 6(12):1125-49. PubMed ID: 10519918
[TBL] [Abstract][Full Text] [Related]
2. Exploring pharmacological significance of chalcone scaffold: a review.
Sahu NK; Balbhadra SS; Choudhary J; Kohli DV
Curr Med Chem; 2012; 19(2):209-25. PubMed ID: 22320299
[TBL] [Abstract][Full Text] [Related]
3. Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry.
Maurya A; Agrawal A
Mini Rev Med Chem; 2024; 24(2):176-195. PubMed ID: 37497710
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory trends of 1, 3-diphenyl-2-propen-1-one derivatives.
Bukhari SN; Jantan I; Jasamai M
Mini Rev Med Chem; 2013 Jan; 13(1):87-94. PubMed ID: 22876943
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of picornavirus uncoating as antiviral agents.
Diana GD; Otto MJ; McKinlay MA
Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
[No Abstract] [Full Text] [Related]
6. Synthesis and biological activities of fluorinated chalcone derivatives.
Nakamura C; Kawasaki N; Miyataka H; Jayachandran E; Kim IH; Kirk KL; Taguchi T; Takeuchi Y; Hori H; Satoh T
Bioorg Med Chem; 2002 Mar; 10(3):699-706. PubMed ID: 11814858
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumorigenic chalcones.
Shibata S
Stem Cells; 1994 Jan; 12(1):44-52. PubMed ID: 8142919
[TBL] [Abstract][Full Text] [Related]
8. Chalcones as Promising Lead Compounds on Cancer Therapy.
León-González AJ; Acero N; Muñoz-Mingarro D; Navarro I; Martín-Cordero C
Curr Med Chem; 2015; 22(30):3407-25. PubMed ID: 26219392
[TBL] [Abstract][Full Text] [Related]
9. Antitumorigenic activities of chalcones. I. Inhibitory effects of chalcone derivatives on 32Pi-incorporation into phospholipids of HeLa cells promoted by 12-O-tetradecanoyl-phorbol 13-acetate (TPA).
Iwata S; Nishino T; Nagata N; Satomi Y; Nishino H; Shibata S
Biol Pharm Bull; 1995 Dec; 18(12):1710-13. PubMed ID: 8787793
[TBL] [Abstract][Full Text] [Related]
10. The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs.
Kamal A; Kashi Reddy M; Viswanath A
Expert Opin Drug Discov; 2013 Mar; 8(3):289-304. PubMed ID: 23317445
[TBL] [Abstract][Full Text] [Related]
11. Secondary Metabolites from Acremonium Fungi: Diverse Structures and Bioactivities.
Tian J; Lai D; Zhou L
Mini Rev Med Chem; 2017; 17(7):603-632. PubMed ID: 27633747
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.
Chen M; Zhai L; Christensen SB; Theander TG; Kharazmi A
Antimicrob Agents Chemother; 2001 Jul; 45(7):2023-9. PubMed ID: 11408218
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
Kumar SK; Hager E; Pettit C; Gurulingappa H; Davidson NE; Khan SR
J Med Chem; 2003 Jul; 46(14):2813-5. PubMed ID: 12825923
[TBL] [Abstract][Full Text] [Related]
14. Efficient liquid-phase synthesis of 2'-hydroxychalcones.
Stoyanov EV; Champavier Y; Simon A; Basly JP
Bioorg Med Chem Lett; 2002 Oct; 12(19):2685-7. PubMed ID: 12217354
[TBL] [Abstract][Full Text] [Related]
15. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
16. Iminosugars and relatives as antiviral and potential anti-infective agents.
Greimel P; Spreitz J; Stütz AE; Wrodnigg TM
Curr Top Med Chem; 2003; 3(5):513-23. PubMed ID: 12570863
[TBL] [Abstract][Full Text] [Related]
17. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A
Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256
[TBL] [Abstract][Full Text] [Related]
18. Antiobesity, antioxidant and cytotoxicity activities of newly synthesized chalcone derivatives and their metal complexes.
El Sayed Aly MR; Abd El Razek Fodah HH; Saleh SY
Eur J Med Chem; 2014 Apr; 76():517-30. PubMed ID: 24602794
[TBL] [Abstract][Full Text] [Related]
19. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation.
Ramalho SD; Bernades A; Demetrius G; Noda-Perez C; Vieira PC; Dos Santos CY; da Silva JA; de Moraes MO; Mousinho KC
Chem Biodivers; 2013 Nov; 10(11):1999-2006. PubMed ID: 24243608
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis, antiprotozoal and cytotoxicity activities of rhuschalcone VI and analogs.
Mihigo SO; Mammo W; Bezabih M; Andrae-Marobela K; Abegaz BM
Bioorg Med Chem; 2010 Apr; 18(7):2464-73. PubMed ID: 20304658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
